Kayne Anderson Rudnick Investment Management LLC Has $54.36 Million Position in Mettler-Toledo International, Inc. $MTD

Key Points

• Kayne Anderson Rudnick Investment Management LLC has reduced its stake in Mettler-Toledo International by 8.8%, now owning approximately 0.22% of the company valued at $54.36 million.
• Mettler-Toledo International reported $10.09 earnings per share for the last quarter, exceeding analysts' expectations of $9.58, with a revenue increase of 3.9% year-over-year.
• Analyst ratings for the company show a consensus of "Moderate Buy", with target prices varying from $1,110 to $1,350.

Kayne Anderson Rudnick Investment Management LLC reduced its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 8.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 46,033 shares of the medical instruments supplier's stock after selling 4,427 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned about 0.22% of Mettler-Toledo International worth $54,361,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Greenleaf Trust grew its stake in shares of Mettler-Toledo International by 1.2% during the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock valued at $1,030,000 after purchasing an additional 10 shares during the last quarter. Brooklyn Investment Group boosted its stake in Mettler-Toledo International by 12.8% in the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock valued at $104,000 after acquiring an additional 10 shares during the last quarter. Albion Financial Group UT boosted its stake in Mettler-Toledo International by 1.5% in the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock valued at $890,000 after acquiring an additional 11 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in Mettler-Toledo International by 1.8% in the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock valued at $740,000 after acquiring an additional 11 shares during the last quarter. Finally, TD Private Client Wealth LLC boosted its stake in Mettler-Toledo International by 5.4% in the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock valued at $253,000 after acquiring an additional 11 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, insider Gerry Keller sold 165 shares of the firm's stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the sale, the insider directly owned 94 shares in the company, valued at $123,012.16. This trade represents a 63.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the firm's stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares in the company, valued at approximately $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,827 shares of company stock worth $2,371,208. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Price Performance

MTD traded up $19.63 during mid-day trading on Friday, hitting $1,302.74. The stock had a trading volume of 100,599 shares, compared to its average volume of 151,491. The stock's fifty day simple moving average is $1,240.96 and its 200-day simple moving average is $1,185.95. The firm has a market capitalization of $26.84 billion, a price-to-earnings ratio of 32.99, a price-to-earnings-growth ratio of 3.90 and a beta of 1.34. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. The company had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period last year, the business posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

MTD has been the topic of a number of recent research reports. Evercore ISI reduced their price objective on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Jefferies Financial Group raised shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and reduced their price objective for the company from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Wall Street Zen cut shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Citigroup raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research note on Thursday, August 21st. Finally, Wells Fargo & Company raised their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research note on Monday, May 5th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $1,311.11.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.